Regional Anesthesia for Knee Prothesis Surgery

Regional Blockade for Knee Prothesis Surgery: Comparison Between Femoral, Sciatic and Adductor Canal Block

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02451605

Enrollment

Registered

2015-05-22

Start date

2015-06-30

Completion date

2015-12-31

Last updated

2015-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Total Knee Replacement

Keywords

surgery

Brief summary

Comparison of the analgesics blocks (femoral, adductor canal and sciatic subgluteal nerve) for total replacement knee surgery.

Detailed description

Adductor canal block shows a beneficial effect for knee surgery. Mainly because he prevent for muscular weakness; adverse effect meet with femoral block and delaying the early active mobilization. The investigators want to compare the efficacy and safety of this block compared to the femoral and sciatic block.

Interventions

DRUGAnalgesic nerve blockade (Ropivacaine)

Analgesic nerve blockade (Ropivacaine) for total knee replacement surgery.

PROCEDURETotal knee replacement surgery.

Total knee replacement surgery.

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to 75 Years

Healthy volunteers

Yes

Inclusion criteria

* patients scheduled for total knee replacement surgery.

Exclusion criteria

* refusal to study, * coagulation disorder, * infection at the puncture site, * preexisting neuropathy, * allergy to local anesthetics, * renal or hepatocellular insufficiency, * context of chronic pain, * drugs abuse, * pregnant patient.

Design outcomes

Primary

Measure	Time frame	Description
Pain measurement with numeric pain scale : from 0 to 10 (maximal pain) in rest condition	up to day 7	Pain assessment and evolution in postoperative period (passive condition)
Pain measurement with numeric pain scale (from 0 to 10) during active motorized mobilization (Kinetic)	up to day 7	Pain assessment and evolution in postoperative period (active condition)

Secondary

Measure	Time frame	Description
Postintervention nausea vomiting	at hour 0, at hours 6, at day 1	question : present or not
Patient satisfaction	at day 1	Questionnaire of patient felling and satisfaction. Choice within gradual felling : bad, middle, good, excellent
Opioid consumption	up to 48 hours	doses of piritramid (synthetic opioid) administrated with patient control rescue analgesia device.

Countries

Belgium

Contacts

Primary ContactPierre Goffin

goffin.pjc@gmail.com003243667178

Backup ContactJean-Pierre Lecoq

jplecoq@chu.ulg.ac.be003243667178

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026